Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results

Journal of Clinical Oncology

Volumn 28, Issue 16, 2010, Pages 2732-2738

  Feng, Felix Y ^a   Kim, Hyungjin M ^a   Lyden, Teresa H ^a   Haxer, Marc J ^a   Worden, Francis P ^a   Feng, Mary ^a   Moyer, Jeffrey S ^a   Prince, Mark E ^a   Carey, Thomas E ^a   Wolf, Gregory T ^a   Bradford, Carol R ^a   Chepeha, Douglas B ^a   Eisbruch, Avraham ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSPHAGIA; EATING DOMAIN OF THE HEAD AND NECK QUALITY OF LIFE QUESTIONNAIRE; ESOPHAGUS; FEEDING APPARATUS; FEMALE; FLUOROSCOPY; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLOTTIS; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARYNX; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; OROPHARYNX CANCER; OROPHARYNX CARCINOMA; PHARYNGEAL MUSCLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK REDUCTION; SALIVARY GLAND; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SUPRAGLOTTIC LARYNX; SWALLOWING; TREATMENT DURATION; TREATMENT OUTCOME; VIDEOFLUOROSCOPY; ADJUVANT THERAPY; CANCER STAGING; COMPARATIVE STUDY; DRUG EFFECT; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; OBSERVER VARIATION; OROPHARYNX TUMOR; PATHOLOGY; PROBABILITY; QUALITY OF LIFE; RADIATION EXPOSURE; RADIATION RESPONSE; RISK ASSESSMENT; SURVIVAL;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; DEGLUTITION; DEGLUTITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OBSERVER VARIATION; OROPHARYNGEAL NEOPLASMS; PROBABILITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77954940229     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.6199     Document Type: Article

References (48)

1. Rosenthal DI, Lewin JS, Eisbruch A: Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24:2636-2643, 2006
2. Logemann JA, Pauloski BR, Rademaker AW, et al: Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 30:148-158, 2008
3. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, et al: Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26:3770-3776, 2008
4. Eisbruch A, Schwartz M, Rasch C, et al: Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60:1425-1439, 2004
5. Feng FY, Kim HM, Lyden TH, et al: Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 68:1289-1298, 2007
6. Caglar HB, Tishler RB, Othus M, et al: Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 72:1110-1118, 2008
7. Dirix P, Abbeel S, Vanstraelen B, et al: Dysphagia after chemoradiotherapy for head and neck cancer: Dose-effect relationships for the swallowing structures. Int J Rad Onc Biol Phys 75:385-392, 2009
8. Dornfeld K, Simmons JR, Karnell L, et al: Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 68:750-757, 2007
9. Werbrouck J, De Ruyck K, Duprez F, et al: Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: Influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 73:1187-1195, 2009
10. Levendag PC, Teguh DN, Voet P, et al: Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 85:64-73, 2007
11. Jensen K, Lambertsen K, Grau C: Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: Frequency, intensity and correlation with dose and volume parameters. Radiother Oncol 85:74-82, 2007
12. Langendijk JA, Doornaert P, Rietveld DH, et al: A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 90:189-195, 2009
13. Eisbruch A, Lyden T, Bradford CR, et al: Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53:23-28, 2002
14. Karnell MP, MacCracken E: A database information storage and reporting system for videofluorographic oropharyngeal motility (OPM) swallowing evaluations. Am J Speech Language Pathol 3:54-60, 1994
15. Logemann JA: Evaluation and Treatment of (ed 2). Austin, TX, PRO-ED, 1998
16. Terrell JE, Nanavati KA, Esclamado RM, et al: Head and neck cancer-specific quality of life: Instrument validation. Arch Otolaryngol Head Neck Surg 123:1125-1132, 1997
17. Hassan SJ, Weymuller EA Jr: Assessment of quality of life in head and neck cancer patients. Head Neck 15:485-496, 1993
18. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 38:963-974, 1982
19. de Arruda FF, Puri DR, Zhung J, et al: Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64:363-373, 2006
20. Chao KS, Ozyigit G, Blanco AI, et al: Intensity-modulated radiation therapy for oropharyngeal carcinoma: Impact of tumor volume. Int J Radiat Oncol Biol Phys 59:43-50, 2004
21. Eisbruch A, Marsh LH, Dawson LA, et al: Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59:28-42, 2004
22. Sanguineti G, Gunn GB, Endres EJ, et al: Patterns of locoregional failure after exclusive IMRT for oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 72:737-746, 2008
23. Yao M, Nguyen T, Buatti JM, et al: Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol 29:606-612, 2006
24. Schoenfeld GO, Amdur RJ, Morris CG, et al: Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 71:377-385, 2008
25. Ogino I, Tsukuda M, Inoue T, et al: Prognostic value of retropharyngeal node involvement in CT-based lymph node-positive pharyngeal cancer following radiotherapy. Anticancer Res 27:1663-1668, 2007
26. Fakhry C, Gillison ML: Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24:2606-2611, 2006
27. Belafsky PC, Mouadeb DA, Rees CJ, et al: Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 117:919-924, 2008
28. Stoeckli SJ, Huisman TA, Seifert B, et al: Interrater reliability of videofluoroscopic swallow evaluation. Dysphagia 18:53-57, 2003
29. Gluck I, Feng FY, Lyden TH, et al: How should we assess and report dysphagia following chemoradiation for head and neck cancer? Int J Radiat Oncol Biol Phys [e-pub ahead of print on September 22, 2009]
30. Jensen K, Bonde Jensen A, Grau, C: The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer: A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 78:298-305, 2006
31. Logemann JA, Pauloski BR, Rademaker AW, et al: Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 25:432-437, 2003
32. Murry T, Madasu R, Martin A, et al: Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer. Head Neck 20:31-37, 1998
33. Logemann JA, Rademaker AW, Pauloski BR, et al: Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 28:64-73, 2006
34. Gillespie MB, Brodsky MB, Day TA, et al: Laryngeal penetration and aspiration during swallowing after the treatment of advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 131:615-619, 2005
35. Hancock SB, Krempl GA, Canfield V, et al: Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy. Laryngoscope 118:1357-1361, 2008
36. Shiley SG, Hargunani CA, Skoner JM, et al: Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 134:455-459, 2006
37. Machtay M, Rosenthal DI, Hershock D, et al: Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: A University of Pennsylvania Phase II Trial. J Clin Oncol 20:3964-3971, 2002
38. Murphy BA, Gilbert J: Dysphagia in head and neck cancer patients treated with radiation: Assessment, sequelae, and rehabilitation. Semin Radiat Oncol 19:35-42, 2009
39. Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 41:582-592, 2003
40. Sloan JA, Frost MH, Berzon R, et al: The clinical significance of quality of life assessments in oncology: A summary for clinicians. Support Care Cancer 14:988-998, 2006
41. Nguyen NP, Frank C, Moltz CC, et al: Aspiration rate following chemoradiation for head and neck cancer: An underreported occurrence. Radiother Oncol 80:302-306, 2006
42. Kotz T, Costello R, Li Y, et al: Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26:365-372, 2004
43. Goguen LA, Posner MR, Norris CM, et al: Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 134:916-922, 2006
44. Langerman A, Maccracken E, Kasza K, et al: Aspiration in chemoradiated patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 133:1289-1295, 2007
45. Nguyen NP, Frank C, Moltz CC, et al: Analysis of factors influencing aspiration risk following chemoradiation for oropharyngeal cancer. Br J Radiol 82:675-680, 2009
46. Bleier BS, Levine MS, Mick R, et al: Dysphagia after chemoradiation: Analysis by modified barium swallow. Ann Otol Rhinol Laryngol 116:837-841, 2007
47. Webster G, Rowbottom CG, Ho KF, et al: Evaluation of larynx sparing techniques with IMRT when treating the head and neck. Int J Radiat Oncol Biol Phys 72:617-622, 2008
48. Caudell JJ, Burnett OL, Schaner PE, et al: Comparison of methods to reduce dose to swallowingrelated structures in head and neck cancer. Int J Rad Onc Biol Phys doi:10.1016/j.ijrobp.2009.05.020 [epub ahead of print on July 3, 2009]